Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (682)

1

Dupilumab : a new treatment for severe T2 high asthma

enthalten in: Revue medicale de Liege | 2024

von Louis, R. | Sabbe, M. | Bougard, N. | +2

2

Pembrolizumab in adjuvant therapy in non-small cell lung cancers

enthalten in: Bulletin du cancer | 2024

von Lefèvre, A. | Tissot, C.

3

Pembrolizumab with trastuzumab and chemotherapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS≥1

enthalten in: Bulletin du cancer | 2024

von Lévêque, I. | Spitzer, E.

4

enthalten in: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2024

von Watt, J. | Isaranuwatchai, W. | Grossman, L. | +1

5

Tezepelumab (Tezspire®) : new biological treatment of severe asthma

enthalten in: Revue medicale de Liege | 2024

von Schleich, F. | Sabbe, M. | Moermans, C. | +1

6

Cemiplimab in association to chemotherapy in advanced non-small cell lung cancer

enthalten in: Bulletin du cancer | 2023

von Rousseau, A. | Auclin, �.

7

Effects of belimumab on ulcerative keratitis in Sjögren's syndrome : Report of two cases

enthalten in: Journal francais d'ophtalmologie | 2023

von Elmaleh, V. | Ottavi, M. | Baillif, S. | +1

8

enthalten in: Revue medicale suisse | 2023

von Gobet, M.

9

Teprotumumab for the treatment of thyroid eye disease : The Holy grail, really?

enthalten in: Journal francais d'ophtalmologie | 2023

von Martel, A.

10

New drug approval : Loncastuximab tesirine in diffuse large B-cell lymphoma relapsed/refractory after two lines of treatment

enthalten in: Bulletin du cancer | 2023

von Tauveron-Jalenques, U. | Bay, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[69]